Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) EPS (Weighted Average and Diluted) (2016 - 2022)

Historic EPS (Weighted Average and Diluted) for Aptevo Therapeutics (APVO) over the last 5 years, with Q4 2022 value amounting to -$0.95.

  • Aptevo Therapeutics' EPS (Weighted Average and Diluted) rose 2519.69% to -$0.95 in Q4 2022 from the same period last year, while for Sep 2023 it was $1.82, marking a year-over-year increase of 103551.03%. This contributed to the annual value of $1.57 for FY2022, which is 12586.49% up from last year.
  • According to the latest figures from Q4 2022, Aptevo Therapeutics' EPS (Weighted Average and Diluted) is -$0.95, which was up 2519.69% from $0.03 recorded in Q3 2022.
  • Over the past 5 years, Aptevo Therapeutics' EPS (Weighted Average and Diluted) peaked at $0.04 during Q1 2022, and registered a low of -$1.75 during Q2 2021.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.66, with a median of -$0.47 in 2018.
  • Per our database at Business Quant, Aptevo Therapeutics' EPS (Weighted Average and Diluted) tumbled by 9990.17% in 2018 and then soared by 10226.66% in 2022.
  • Aptevo Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at $0.0 in 2018, then tumbled by 73931.68% to -$1.27 in 2021, then rose by 25.2% to -$0.95 in 2022.
  • Its EPS (Weighted Average and Diluted) was -$0.95 in Q4 2022, compared to $0.03 in Q3 2022 and $0.03 in Q2 2022.